Publications by authors named "G Liumbruno"
Article Synopsis
- Therapeutic apheresis (TA) is a special treatment for patients with serious illnesses that don't get better with regular medicine.
- Researchers gathered data from over 104,000 TA procedures on more than 15,000 patients to learn more about its effects and outcomes.
- Most patients needed it to collect stem cells for treatment, and the number of side effects has gone down a lot in recent years, showing that the treatment is becoming safer.
In Italy, an HLA-matched unrelated donor is currently the primary donor when a HLA matched sibling is not found for allogeneic haematopoietic stem cell transplantation (HSCT). Better outcomes for transplantation require optimal matching between donor and recipient at least at the HLA-A, -B, -C, and -DRB1 loci; therefore, the availability of HLA-matched unrelated donors is important. The enormous HLA polymorphism has always necessitated registries with a large number of individuals in order to be able to provide well-matched donors to a substantial percentage of patients.
View Article and Find Full Text PDF